Introduction
Staphylococcus epidermidis infections have emerged as a major problem in modern medicine. As an organism that is typically encountered as a commensal of human skin and mucous membranes (Otto, 2010; Grice and Segre, 2011) , S. epidermidis is a prototypic opportunistic pathogen, causing infections almost exclusively in predisposed hosts. The risk factor most significantly associated with development of an infection is the use of implanted foreign materials, such as prosthetic joints, artificial heart valves and central venous catheters (Darouiche, 2004) . S. epidermidis is one of the most common organisms found in various types of medical device-associated infections (Donlan, 2001; Sievert et al., 2013) and the number one cause of healthcare associated-bloodstream infections, which are often secondary to medical device infections (Rupp, 2014) . The coagulase-negative staphylococci (CoNS), of which S. epidermidis is the most abundant, are consistently reported within the top ten etiological agents in healthcare-associated infection (Sievert et al., 2013; Magill et al., 2014) . There is clearly a need for effective treatment and prevention of S. epidermidis infections, which will require a detailed understanding of its pathogenesis.
The pathogenicity of S. epidermidis is linked to its ability to form adherent, multi-layered biofilms on artificial surfaces (Mack et al., 2009; Otto, 2014b) . The biofilm mode of growth protects bacteria from host immune defences, as well as antibiotics, resulting in persistent infections that are difficult to treat (Arciola et al., 2012;  Accepted 1 December, 2016. *For correspondences. E-mail rohde@uke.de; Tel. 149 40 7410 52143; Fax 149 40 7410 53250 and E-mail alex-horswill@uiowa.edu; . †These authors contributed equally to this work. Morgenstern et al., 2016; Paharik and Horswill, 2016) . Biofilm maturation requires bacterial adhesins that mediate intercellular attachment and the eventual formation of an established biofilm structure. Research over the past two decades has identified several mechanisms that promote intercellular adhesion and biofilm accumulation in S. epidermidis. Polysaccharides, proteins, and extracellular DNA (eDNA) are the underlying functional molecules in the biofilm matrix. Despite sharing functional properties, these molecules differ with respect to their spatial organization within the biofilm. For example, the polysaccharide intercellular adhesin (PIA), synthesized by proteins encoded in the icaADBC operon, forms a sticky, glue-like extracellular matrix, while the cell wall-bound accumulation associated protein (Aap) strictly localizes to the bacterial cell surface (Schommer et al., 2011; B€ uttner et al., 2015) . These apparent structural differences also result in distinct macroscopic and microscopic morphological phenotypes, and might reflect the ability of S. epidermidis to employ distinct biofilm forming modalities depending on the particular physical stresses present at different infection sites (Otto, 2014a) . In support of this concept, a recent analysis of S. epidermidis clinical isolates found that the ica operon was more prevalent in strains that infected body sites with high shear stress, compared with those infecting lower-shear environments (Schaeffer et al., 2016) . This suggests that PIA-independent, protein-dependent biofilms may be particularly relevant to infections in lowshear host niches.
Although PIA was previously considered to be essential for S. epidermidis biofilm development, multiple studies have reported that at least 30% of invasive isolates lack the icaADBC operon for PIA biosynthesis, with some infection types containing as many as 74% icanegative isolates (Ziebuhr et al., 1997; Klug et al., 2003; Rohde et al., 2007; Hellmark et al., 2013) . The cell wallanchored adhesin Aap plays a critical role in biofilm formation in the absence of PIA (Hussain et al., 1997; Rohde et al., 2005; Hennig et al., 2007) . In a rat central venous catheter model of S. epidermidis infection, an ica mutant in strain 1457 had no defect, while a single mutant lacking Aap was severely attenuated (Schaeffer et al., 2015) , demonstrating that in certain infections, Aap-mediated surface colonization is favoured. Thus, understanding the molecular determinants promoting Aap-dependent biofilm formation is crucial for the development of novel approaches to combat S. epidermidis device-related infections.
Aap and its S. aureus orthologue SasG are sortaseanchored cell wall proteins that have been shown to promote both cell-surface and cell-cell adhesion. These proteins have two major domains, with the N-terminal A domain containing a predicted, 212 amino acid L-type lectin domain of unknown ligand specificity (Fig. 1) . The A domain has been shown to mediate primary attachment of bacteria to abiotic surfaces as well as to mammalian epithelial cell monolayers (Roche et al., 2003; Macintosh et al., 2009; Conlon et al., 2014; Schaeffer et al., 2015) . The B domain is composed of several repeating G5 motifs with intervening E repeat spacers (Fig. 1) . Heterotypic interactions between B domain and Small basic protein (Sbp), a component of the biofilm matrix, contribute to Aap-dependent biofilm formation (Decker et al., 2015) . In addition, extensive biochemical characterization has provided evidence for homotypic B Fig. 1 . Diagram of S. epidermidis 1457 Accumulation-Associated Protein (Aap). Aap contains a YSIRK/GS-type signal peptide, an A domain consisting of A repeats and a lectin domain, and a B domain consisting of G5 domains with intervening spacer regions, referred to as E domains. The C terminal portion of the protein contains a proline/glycine-rich region and a cell wall anchor, including the LPXTG recognition site for Sortase A. The molecular weights shown correspond to the full-length protein and the cleavage products cut at amino acids 335 and 601. Molecular weights are predicted by ExPASY ProtParam tool and exclude the signal peptide N terminal to the AXA signal peptidase cleavage site.
domain interactions, leading to Zn 21 -dependent assembly of a strong, elongated twisted rope-like structure that promotes intercellular accumulation (Corrigan et al., 2007; Conrady et al., 2008; Kuroda et al., 2008; Geoghegan et al., 2010; Gruszka et al., 2012; Conrady et al., 2013; Gruszka et al., 2015; Formosa-Dague et al., 2016) . However, this process and its resulting biofilm maturation only occur once the A domain is proteolytically removed (Rohde et al., 2005) . The necessity of proteolytic cleavage highlights the specific importance of proteases for Aap function as an intercellular adhesin, and also demonstrates that proteolytic processing is of fundamental importance for S. epidermidis to dynamically adjust functional cell surface properties. Strikingly, despite its obvious importance, the involvement of one or more specific S. epidermidis proteases in Aap processing and modulation of biofilm formation is unknown. S. epidermidis secretes three major proteases: a metalloprotease SepA, a cysteine protease Ecp and a serine protease Esp (Teufel and Gotz, 1993; Moon et al., 2001; Oleksy et al., 2004) . Research on the role of proteases in staphylococcal biofilms has focused on the dispersal phase of the biofilm life cycle, in which the biofilm matrix is degraded and bacterial cells return to a free, planktonic state (Boles and Horswill, 2008; Tsang et al., 2008; Mootz et al., 2013) . The secreted S. epidermidis serine protease Esp is well known as an inhibitor of S. aureus biofilm formation and colonization (Sugimoto et al., 2013) . Esp can degrade existing S. aureus biofilms by cleaving specific proteins in the biofilm matrix (Iwase et al., 2010; Sugimoto et al., 2013) , and can prevent S. aureus biofilm formation by degrading the autolysin Atl, thereby eliminating eDNA production in the biofilm matrix (Chen et al., 2013) . The functions of Ecp and SepA in the biofilm life cycle are less well characterized.
In this report, we show that PIA-independent biofilm formation in S. epidermidis requires the secreted protease SepA. Aap processing is dependent on SepA, and studies with recombinant Aap showed that SepA is able to cleave Aap at two residues: Leu 335 and Leu 601. The global regulator SarA negatively regulates sepA and therefore inhibits SepA-mediated biofilm formation. The present study gives novel insights into the molecular mechanisms used by S. epidermidis to regulate biofilm formation by posttranslational mechanisms.
Results
SepA is required for PIA-independent S. epidermidis biofilm formation
In the absence of PIA, S. epidermidis forms a proteindependent biofilm that is primarily mediated by the cell wall-anchored adhesin Aap, which requires processing by an unknown staphylococcal protease (Rohde et al., 2005; Schaeffer et al., 2015) . To characterize the mechanism of protein-dependent biofilm formation, we used an allelic replacement mutant of the icaADBC operon in the S. epidermidis central venous catheter infection isolate 1457 (Mack et al., 1992) . 1457Dica was used as the reference strain in all biofilm experiments in this study. As expected, mutation of aap in 1457Dica completely abolished biofilm formation in a microtiter plate assay ( Fig. 2A) . To investigate the importance of secreted proteases in this Aap-dependent biofilm, we tested mutants of the secreted metalloprotease SepA and cysteine protease Ecp. We found that biofilm formation in a microtiter plate assay was greatly reduced in the 1457DicaDsepA mutant, to a similar extent as the 1457DicaDaap mutant ( Fig. 2A) . The 1457DicaDecp mutant showed a modest defect in biofilm formation as well, although complementation on a high-copy plasmid did not restore biofilm formation (data not shown). To more accurately model the in vivo conditions of a S. epidermidis biofilm infection, we tested the 1457Dica and 1457DicaDsepA strain pair in a flow cell biofilm ( Fig.  2C-F) . Biomass was greatly reduced in 1457DicaDsepA as assessed by confocal laser scanning microscopy ( Fig. 2E, F vs. 2C,D) and as demonstrated by quantification of the biomass across several images (Fig. 2B) .
The level of SepA activity correlates with Aap-dependent biofilm formation
To further examine the role of SepA, a complementing sepA plasmid (psepA) was constructed using a staphylococcal vector backbone (Pang et al., 2010) . psepA completely restored biofilm capacity to the 1457DicaDsepA mutant compared with a vector control (Fig. 3A) . To confirm this result, we tested biofilm formation of 1457DicaDsepA treated with exogenously added protease. Mature SepA shares 79.3% amino acid identity with its S. aureus orthologue Aureolysin (Aur) and both are able to degrade casein (Arvidson, 1973; Teufel and Gotz, 1993) . We, therefore, hypothesized that Aur could substitute for SepA activity. The addition of purified Aur enhanced biofilm formation of 1457DicaDsepA (Fig. 3B) . A dose-dependent increase in biofilm formation in 1457Dica treated with Aur was also observed (Fig. 3C) , even though this strain secretes SepA. This observation suggests that endogenous SepA activity is not high enough to maximally promote biofilm formation in our WT strain.
To assess the Aap dependence of these biofilm phenotypes, 1457Dica and 1457DicaDaap were treated with either purified Aur or transformed with psepA plasmid. No increase in biofilm formation was observed with the addition of Aur to 1457DicaDaap (Fig. 3C) . Similarly, the psepA complementation plasmid did not enhance biofilm formation in the 1457DicaDaapDsepA mutant (Fig. 3D) , further indicating the Aap dependence of the biofilm. Altogether, these results suggest that SepA/Aur enhance S. epidermidis biofilm formation and that this mechanism requires Aap.
Biofilm formation and SepA activity are repressed by SarA
SarA is a global transcriptional regulator that has been demonstrated to strongly repress expression of the secreted proteases in S. aureus (Shaw et al., 2004; Cassat et al., 2006) . Although casein zymography has previously suggested increased protease activity in S. epidermidis sarA mutants (Lai et al., 2007) , we sought to test SarA regulation of sepA by quantitative RT-PCR as well as a SepA-specific activity assay. Quantitative RT-PCR was used to compare expression of sepA, ecp and esp in S. epidermidis 1457Dica and 1457DicaDsarA. After 6 h of growth, sepA expression was 22.3-fold up-regulated in 1457DsarA (Table 1 ; p < 0.001; CI 19.1-26.1). In contrast, no significant regulation was observed for ecp or esp (Table 1) respectively. sepA up-regulation was still evident after 16 h of growth (7.8-fold up-regulation; CI 2.2-27.2; p < 0.05). Still, no regulation of ecp became apparent, while there was a slight but significant up-regulation of esp (6.3-fold up-regulation; CI: 2.4-16.9; p < 0.01).
To test SepA activity in S. epidermidis, we used a fluorescein-labelled peptide that is cleaved by Aur between the Asn and Ile residues (Kavanaugh et al., 2007) . We hypothesized that SepA would cleave this substrate at the same site (Fig. 4A) . In S. epidermidis, low-level SepA activity was observed at the expected cleavage site (Fig.  4B , note faint band). This activity was diminished in 1457DicaDsepA. In accordance with transcriptional data, the fluorescein-labelled peptide assay revealed greatly increased SepA activity in 1457DicaDsarA. This activity was decreased in the 1457DicaDsarADsepA mutant, confirming that enhanced protease activity in 1457DicaDsarA is SepA-mediated (Fig. 4B ). Although SarA did not affect ecp transcription, we tested whether Ecp activity was altered in a DsarA mutant using a FRET substrate based on the CXCR2 neutrophil receptor protein, which is cleaved by the S. aureus protease ScpA ( Fig. 4C ) (Laarman et al., 2012; . We found that activity was enhanced approximately three-fold in 1457DicaDsarA compared with 1457Dica, indicating that SarA represses Ecp at a post-transcriptional level (Fig.  4D ). Due to the lack of an Esp-specific substrate, SarA regulation of Esp activity was not tested. Since we have observed enhanced biofilm formation in conditions with increased SepA activity, we tested the impact of SarA on PIA-independent biofilm formation. As expected, the 1457DicaDsarA mutant had markedly enhanced biofilm formation in this background, but the 1457DicaDsarADsepA displayed a biofilm phenotype similar to that of 1457DicaDsepA (Fig. 4E ). These observations indicated that the SarA-mediated enhancement in biofilm formation is due to increased SepA activity. Since SarA also represses Ecp activity, we tested whether Ecp contributed to the biofilm phenotype of the DsarA mutant. However, biofilm formation in 1457DicaDsarADecp was similar to 1457DicaDsarA, suggesting that Ecp is not required for SarA-mediated biofilm enhancement (Fig .   Fig. 3 . Complementation of sepA mutant by plasmid and exogenous protease. Strains were grown statically for 20 h in 48-well microtiter plates. With the exception of (C), one-way ANOVA with multiple comparisons (Bonferroni correction) was performed. * indicates p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. A. Microtiter biofilm assay using strains complemented with psepA. Results are pooled from three experiments with three replicates each. B. Microtiter biofilm assay with Aureolysin (Aur) added to complement 1457DicaDsepA. Results are pooled from two experiments with three replicates each. C. Microtiter biofilm assay with Aur added to 1457Dica and 1457DicaDaap. One representative experiment is shown. Two-way ANOVA with multiple comparisons (Bonferroni correction) was performed. D. Microtiter biofilm assay using strains complemented with psepA. Results are pooled form three experiments with three replicates each. 4D). This indicates that even with enhanced Ecp activity, this protease does not detectably contribute to biofilm formation under these conditions.
SepA promotes Aap processing in S. epidermidis
Multiple previous studies have shown that the B domain of Aap and its S. aureus orthologue SasG facilitate intercellular adhesion and biofilm maturation by forming a Zn 21 -dependent twisted rope structure (Geoghegan et al., 2010; Conrady et al., 2013) . In Aap, proteolytic removal of the A domain is required to allow B domainmediated intercellular adhesion to occur (Rohde et al., 2005) . We hypothesized that Aap-mediated biofilm enhancement by SepA occurs through processing of Aap. To investigate this question, Western blots of cell wall preparations were performed using an antibody to the B domain of Aap. The cell wall of 1457Dica revealed two prominent bands running above and below 250 kDa standard (Fig. 5A ), corresponding to full-length and processed Aap (Fig. 1) . Multiple faint bands at lower molecular weights were also present, and all of these bands were absent in a 1457DicaDaap mutant control. Although full-length cell wall-anchored Aap is predicted to be 165 kDa, we observed the protein running larger than 250 kDa, which has previously been observed and is possibly due to remaining cell wall fragments from the isolation procedure (Schaeffer et al., 2015) . Processed A. Fluorescein-labelled peptide for activity of S. aureus Aur and S. epidermidis SepA. The cleavage leaves a negatively-charged, fluoresceinlabelled species that can be observed by running the reaction on an agarose gel. B. Activity assay for SepA. Cell-free spent media from S. epidermidis strains was incubated with the fluorescein-labelled substrate. Reactions were run on an agarose gel and visualized under UV light. The negative image of the gel is shown. C. FRET (fluorescence resonance energy transfer)-based substrate for S. aureus ScpA and S. epidermidis Ecp. The peptide has an Nterminal fluorophore and C-terminal quencher linked to the terminal Lys residues. Cleavage allows fluorescence by separating the fluorophore from the quencher. D. Activity assay for Ecp. Cell-free spent media from S. epidermidis strains were incubated with the FRET substrate. Reaction rates (fluorescence/time) were averaged from two experiments with three replicates each and normalized to wild type 1457. E. Microtiter biofilm assay. Results are pooled from three experiments with three replicates each. One-way ANOVA with multiple comparisons (Bonferroni correction) was performed. **** indicates p < 0.0001.
Aap containing only the B domain is expected to run at 200 kDa in these samples (Rohde et al., 2005) and surprisingly, we observed very little of this form of the protein. The observed intermediate band (just below 250 kDa) is likely Aap that is processed within the A domain (Fig. 5A) . In testing protease knockout strains, the 1457DicaDecp mutant showed no change in Aap processing from the 1457Dica background. In contrast, Aap in 1457DicaDsepA shifted almost completely to the full-length form, while in 1457DicaDsepA complemented by psepA the full length-form is absent, with the amount of processed Aap increased.
We also assessed the contribution of the SarA repressor to Aap processing (Fig. 5A ). In 1457DicaDsarA, A. Western blot of cell wall preparations from S. epidermidis 1457Dica background strains. Samples were blotted and analysed using a rabbit anti-rDomain B antiserum. Bound antibodies were detected using anti-rabbit IgG coupled to IR800 (Licor). B. Analysis of rDomain-B_LLD cleavage by incubation with concentrated cell-free supernatants protease overexpressing strain 1457DicaDsarA and corresponding protease knock-out mutants incubated with rDomain-B_LLD. After incubation at 37˚C reactions were loaded onto 4%-15% gradient gels. After separation proteins were stained using Coomassie blue or blotted onto PVDF membrane. Proteins were detected using a mouse anti-His 6 IgG and an anti-mouse IgG coupled to peroxidase. The asterisk indicates band for which the N-terminal sequence was determined. C. Analysis of rDomain-A cleavage by incubation with concentrated cell-free supernatants protease overexpressing strain 1457DicaDsarA and corresponding protease knock-out mutants incubated with rDomain-B 1 212. After incubation at 37˚C reactions were loaded onto 4%-15% gradient gels. After separation proteins were stained using Coomassie blue or blotted onto PVDF membrane. Proteins were detected using a mouse anti-His 6 IgG and an anti-mouse IgG coupled to peroxidase. Results shown in panel B and C were obtained using supernatants from S. epidermidis 1457-M10DsarA and corresponding protease knock-out mutants.
Aap was mostly processed to the intermediate form, as observed with 1457DicaDsepA x psepA, both conditions that have high levels of SepA activity. The 1457DicaDsarADsepA mutant regained full-length Aap, confirming that SepA mediates SarA-increased Aap processing (Fig. 5A) . The 1457DicaDsarADecp mutant displayed the same Aap processing pattern as observed in the 1457DicaDsarA mutant. These results suggest that SepA proteolytically cleaves Aap, and Ecp does not have detectable impact under these conditions. Further, these results mirror the biofilm findings demonstrating that increased SepA, but not Ecp, activity enhances biofilm formation. Since a small amount of processed Aap remains in 1457DicaDsepA, another protease such as Esp may also cleave Aap in this region, or the protein may undergo spontaneous degradation, as has been observed in S. aureus SasG (Geoghegan et al., 2010) .
Mapping of aap cleavage sites
Next, a series of experiments was performed with the goal of defining the SepA cleavage sites within Aap, as well as further test the involvement of the other major secreted proteases, Ecp and Esp, in Aap processing. Due to the instability of recombinant full-length Aap, recombinant Aap fragments carrying an N-terminal His 6 tag were expressed in E. coli and purified by nickel affinity chromatography. These fragments correspond to the A domain (rDomain-A; amino acids 54-614) and the B domain along with the 212 amino acid lectin-like domain portion of the A domain (rDomain-B_LLD; aa 398-1507), thus including the anticipated cleavage site between the A and B domains ( Fig. 1) (Rohde et al., 2005) .
Incubation of rDomain-B_LLD with supernatants of 1457Dica for 30 minutes at 378C did not result in a detectable degradation of the recombinant 123 kDa protein, as investigated by SDS-PAGE and Western blots using anti-His 6 antibodies. In contrast, incubation of rDomain-B_LLD with 1457DicaDsarA supernatants resulted in a rapid decrease of immunoreactivity of the 123 kDa band in anti-His 6 Western blots (Fig. 5B) , while SDS PAGE analysis only documented a slight shift of the protein toward a lower molecular weight. Thus evidence was provided that the Aap degrading activity of the 1457DicaDsarA supernatants leads to an N-terminal degradation of rDomain-B_LLD. Indeed, N-terminal sequencing of non-anti-His 6 reactive protein after 30 minutes of incubation (Fig. 5B) identified amino acids mapping to positions 601-608 of full length Aap, confirming N-terminal cleavage between the 212 amino acid lectin-like domain and the first G5 domain of the Aap B domain (Fig. 1) . The anticipated, N-terminal tagged 23 kDa cleavage product only became apparent in Western blot analysis after 5 minutes of incubation on ice, but also disappeared thereafter (data not shown), suggesting that the lectin-like domain undergoes further degradation, resulting in smaller protein species undetectable by the methods applied here.
Incubation of rDomain-A with supernatants from 1457DicaDsarA, but not from 1457Dica, also led to a rapid degradation of the recombinant protein, associated with the appearance of a 29 kDa protein species detectable by SDS-PAGE (Fig. 5C ). The 29 kDa protein, unlike the mature recombinant protein, was undetectable by anti-His 6 Western blot analysis. Thus, rDomain-A is processed, resulting in removal of its His 6 -tagged N-terminus. N-terminal sequencing of the 29 kDa protein (Fig. 5C ) identified amino acids mapping to 335-343 of the mature Aap protein (Fig. 1) . Taken together, these data suggest that Aap contains at least two independent cleavage sites N-terminal to the positions of amino acid 335 and amino acid 601.
Since we observed enhanced Aap processing in 1457DicaDsarA and 1457DicaDsarADecp, but not 1457DicaDsarADsepA (Fig. 5A) , we predicted that SepA was the primary protease involved in the observed degradation of recombinant Aap sub-domains. Indeed, incubation of rDomain-B_LLD or rDomain-A with concentrated culture supernatants from 1457DicaDsarADsepA did not result in any degradation of the recombinant protein as detected by SDS-PAGE or anti-His 6 Western blot analysis. On the contrary, supernatants of 1457DicaDsarADecp or 1457DicaDsarADesp retained full rDomain-A processing activity. However, a differential pattern was found when rDomain-B_LLD was incubated with supernatants from 1457DicaDsarADecp or 1457DicaDsarADesp. Unlike the findings made using 1457DicaDsarA supernatants, even after 30 minutes of incubation, unprocessed recombinant protein was detectable with almost unchanged (DicaDsarADecp) or lowered (DicaDsarADesp) signal intensity (Fig. 5B) . Furthermore, a 29 kDa, anti-His 6 -reactive band appeared at increasing intensities over time. Thus, despite unchanged sepA expression in 1457DicaDsarADecp and 1457DicaDsarADesp as compared with 1457DicaDsarA (Table 1) , rDomain-B_LLD turn-over is slowed down in the absence of Ecp or Esp. Taken together, these results indicate that SepA is necessary for processing of rDomain-A and rDomain-B_LLD, while Ecp and Esp contribute to processing of rDomain-B_LLD.
Discussion
Staphylococcus epidermidis is a prevalent cause of medical device-associated infections, which are mediated by biofilm formation and are a significant burden to Metalloprotease SepA 867 the healthcare system. Although there are many published studies on S. aureus biofilms, there are fewer mechanistic investigations of biofilm formation in the coagulase-negative staphylococci. Previous work has shown that S. epidermidis can produce a proteindependent biofilm that is primarily mediated by the cell wall adhesin Aap. In this study, we found that SepA is required for Aap-dependent biofilm formation, and SepA acts on Aap by removing the N-terminal domain and promoting the homophilic interactions of this protein necessary for biofilm accumulation. This is the first report of a secreted staphylococcal protease that enhances biofilm capacity. These findings indicate that coagulase-negative staphylococci exhibit distinct biofilm development mechanisms that warrant further investigation.
Early studies on S. epidermidis biofilms focused on PIA as the critical adhesin, biofilm matrix component, and virulence factor in S. epidermidis (Otto, 2009 (Otto, , 2013 . Other mechanisms of biofilm growth were mostly neglected because PIA-negative strains are generally poor biofilm formers in microtiter biofilm assays. However, in a flow cell assay as well as in vivo conditions, a 1457Daap single mutant shows a marked defect in biofilm formation (Schaeffer et al., 2015) These differences are not easily distinguishable in the typical microtiter biofilm assay because PIA can likely compensate for the lack of other adhesins. To focus on PIA-independent, Aap-dependent mechanisms of biofilm formation, we optimized the biofilm assay for a S. epidermidis strain that does not produce PIA (1457Dica). Our results corroborated previous findings that Aap is critical for biofilm formation in the absence of PIA (Schaeffer et al., 2015) . Under these conditions, both Aap and SepA are required for biofilm formation ( Fig. 2A) . We also found that SepA and its S. aureus orthologue Aur enhanced PIA-negative biofilm formation (Fig. 3A-C) , and that this enhancement required Aap (Fig. 3C,D) .
A previous study found that exogenous addition of trypsin or elastase enhanced PIA-negative biofilm formation in the clinical S. epidermidis strain 5179 by cleaving Aap at the juncture between its A and B domains (Rohde et al., 2005) . However, a native staphylococcal protease that processed Aap had not been identified. There has been extensive research describing the structure of the B domain in Aap and SasG, as well as its ability to dimerize. The homodimerization of adjacent Aap proteins forms a twisted rope structure that is able to withstand significant shear force, allowing strong intercellular association (Formosa-Dague et al., 2016) . This process requires Zn 21 , which is coordinated by residues within each G5/E repeat of the B domain (Conrady et al., 2008 (Conrady et al., , 2013 . Interestingly, SepA is a metalloprotease that also requires divalent cations for activity, with a preference for Zn 21 (Teufel and Gotz, 1993) . Therefore, our work shows that Aap-mediated intercellular adhesion requires Zn 21 at two steps, corroborated by previous findings that Zn 21 chelation inhibits SasG-mediated biofilm formation (Geoghegan et al., 2010) . Based on the biofilm phenotypes of the sepA mutant (Fig. 2) , we hypothesized that SepA processed Aap to enhance biofilm formation. Western blots revealed that Aap on the S. epidermidis cell wall is processed to multiple forms, with the most prominent processed band appearing just below 250 kDa, as well as multiple faint bands of lower molecular weight. The samples consistently run at a higher molecular weight than predicted Aap, which has been observed in previous studies of Aap and SasG (Rohde et al., 2005; Geoghegan et al., 2010; Schaeffer et al., 2015) , and may be partially explained by remaining cell wall fragments. Another explanation for the increase in apparent molecular weight is the presence of acidic amino acids (Asp and Glu) in Aap. Multiple studies have reported slowed SDS-PAGE migration of proteins with greater than 11% acidic amino acids (Whitfield et al., 1995; Guan et al., 2015) . According to the ExPASy ProtParam tool, full-length Aap contains 16.5% Asp and Glu residues and has a predicted pI of 4.65. We predict that the most abundant processed form (250 kDa) corresponds to the cleavage product within the A domain at amino acid 335. We expect that the smaller bands represent the product of cleavage at amino acid 601, as well as other potential sites that are present in the repeats of the B domain. Overexpression of sepA, either by a plasmid or in a DsarA mutant, results in a loss of the full-length protein and increased presence of the processed forms (Fig.  5A) . Experiments with recombinant truncations of Aap incubated with S. epidermidis supernatants demonstrated that SepA cleaves Aap at two sites, Leu 335 and Leu 601. While the recombinant experiments showed that Ecp, as well as Esp, have some Aap cleavage activity (Fig. 5D) , this was not observed with the cell wall Western blot, potentially due to the inability to detect these lower abundant cleavage products. Although both the 1457DicaDsepA and 1457DicaDsarADsepA mutants retain some processed Aap, especially the form that is processed within the A domain (Fig. 5A) , their biofilm formation is greatly decreased relative to 1457Dica (Figs. 1 and 2) or 1457DicaDsarA (Fig. 4D) .
In terms of the effect on biofilm formation, the results of the Aap Western blot compared with our biofilm studies suggest a model in which the N terminus of the A domain is inhibitory to biofilm formation. Rather than biofilm formation occurring with the presence of processed Aap, biofilm formation seems to be de-repressed when the full-length form of Aap is lost. Although a previous study showed that the full A domain alone of SasG inhibited SasG-mediated intercellular accumulation (Geoghegan et al., 2010) , it is not known whether it is the entire A domain that is responsible. Our results suggest that the portion N terminal to the lectin domain specifically inhibits biofilm formation. The absence of a cleavage product corresponding to a total loss of the A domain (Fig. 5A) suggests that Aap can mediate intercellular adhesion even when the lectin domain is present. Further, the function of free A domain in the biofilm matrix is not known, nor is the specific ligand bound by the lectin domain of Aap. Clearly, much remains to be clarified regarding the structure and function of Aap.
In S. aureus, the SepA homolog Aureolysin has been reported to be positively regulated by the agr quorumsensing system (Shaw et al., 2004) . A previous report also showed decreased S. epidermidis extracellular protease activity in an Dagr mutant based on casein zymography, which is generally accepted to indicate Aur or SepA metalloprotease activity (Lai et al., 2007) . However, the S. epidermidis DrnaIII mutant does not show differential regulation of sepA compared with wildtype in a microarray . Additionally, the DrnaIII mutant did not demonstrate a loss of SepA activity in our fluorescein-labelled peptide assay (data not shown). Collectively, these findings indicate that sepA is not agr quorum-sensing regulated in S. epidermidis.
SarA has previously been shown to down-regulate extracellular protease activity in S. epidermidis based on a casein zymography assay (Lai et al., 2007) . We found that SarA negatively regulates SepA and Ecp activity using substrates specific to these enzymes (Fig. 4B,C) , and that a DsarA mutant had markedly enhanced biofilm formation and Aap processing relative to 1457Dica (Fig.  4D) , both phenotypes being dependent on SepA. This demonstrates that in an Aap-mediated biofilm, SarA is a strong negative regulator of biofilm formation. Similar observations have recently been made for Embpinduced biofilms, which are also negatively regulated by SarA (Christner et al., 2012) . On the contrary, in icapositive S. epidermidis, DsarA mutants have decreased ica expression and lower biofilm capacity (Tormo et al., 2005; Handke et al., 2007) . Our results highlight the varying effects of this global regulatory system depending on the particular biofilm morphology.
SepA has been shown to enhance S. epidermidis biofilm formation via increased processing of the autolysin AtlE to its active form (Christner et al., 2012) . This phenotype occurs due to strengthening the biofilm matrix with eDNA, since active AtlE induces autolysis. However, the conditions in our study seem to favour a protein-dependent, rather than eDNA-dependent biofilm. Our findings show that SepA enhancement of biofilm formation requires the presence of Aap (Fig. 2) , rather than any other SepA substrate. Further, the previous study would suggest that a sepA mutant should have less eDNA in the biofilm. However, an assay to detect eDNA in the biofilm matrix showed no difference between wild type S. epidermidis 1457 and a sepA mutant in our biofilm growth conditions (data not shown). Therefore, we observe a protein-dependent biofilm that requires Aap and its processing by SepA. Our work shows that SepA has another mechanism to promote biofilm formation in addition to enhancing autolysis.
This finding also supports the possibility of multispecies biofilm formation of S. aureus and S. epidermidis. We found that both SepA and S. aureus Aur can process Aap to its biofilm-inducing form. Although one might predict that both enzymes could also process S. aureus SasG, a previous study did not find that Aur or other secreted S. aureus proteases were required for SasG cleavage (Geoghegan et al., 2010) . Interestingly, the Leu 335 and Leu 601 SepA cleavage residues identified in the present study are absent in all annotated forms of SasG, which suggests that SasG processing may occur via another mechanism. Recent work has also demonstrated that SasG and Aap B domains are able to form heterodimers, providing a mechanism for intercellular adhesion between S. aureus and S. epidermidis in a biofilm (Formosa-Dague et al., 2016) . Because S. aureus Aur can promote S. epidermidis PIA-independent biofilm formation ( Fig. 3) , these collective findings suggest that S. epidermidis might have the ability to co-opt S. aureus protease activity to promote biofilm formation, which could be beneficial in particular shared host niches.
Overall, this work demonstrates that the secreted protease SepA is critical to S. epidermidis proteindependent biofilm formation by processing Aap. Our findings add to previous work showing that SepA helps to defend against the host immune system by cleaving the antimicrobial peptide dermicidin (Lai et al., 2007) and promoting S. epidermidis survival following phagocytosis by human neutrophils (Cheung et al., 2010) . Therefore, SepA has multiple roles as a virulence factor, both promoting the biofilm lifestyle and providing defences against the human innate immune system. Strategies to interfere with S. epidermidis proteolytic activity or Aap processing could open new avenues to treat certain types of biofilm infections.
Experimental procedures

Strains and plasmids
Strains, plasmids, and bacteriophages are listed in Supporting Information Table S1 . Unless otherwise noted, strains were cultured at 378C with 200 RPM shaking. E. coli was grown in lysogeny broth (LB) or on LB agar plates containing 100 mg/ml ampicillin to maintain plasmids when Metalloprotease SepA 869 necessary. S. aureus was grown in tryptic soy broth (TSB) or on TSB agar plates, and S. epidermidis was grown in TSB, on TSB agar plates, or in brain-heart infusion broth (BHI). Staphylococcal plasmids were maintained with growth in 10 mg/ml chloramphenicol. Chromosomal tetM transductants were selected by growth on TSB agar plates containing 2.5 mg/ml tetracycline, and dhfr transductants were selected by growth on TSB agar plates containing 10 lg/ml trimethoprim.
The sepA complementation plasmid psepA was generated by cloning sepA and its promoter region from S. epidermidis 1457 chromosomal DNA using primers E1 and E2 (listed in Supporting Information Table S2 ) into a TOPO vector, then digesting with NheI and XhoI and ligating into pCM29 (Pang et al., 2010) .
Generation of S. epidermidis mutants
An esp allelic replacement mutant was constructed by first cloning 5 0 and 3 0 regions of esp (amplified using primers 2304/2305 and 2306/2307) into the EcoRI-BamHI (5 00 region) and SalI-PstI sites of pUC19 (Yanisch-Perron et al., 1985) . dhfr, encoding trimethoprim resistance (Handke et al., 2007) , and pROJ6448, containing a temperature sensitive gram positive replicon (Projan and Archer, 1989) , were subsequently ligated into the SalI and PstI sites, respectively, to generate pNF281. Allelic replacement experiments with S. epidermidis 1457 were performed as previously described (Schaeffer et al., 2015) . Transfer of plasmids psepA and pCM28 from E. coli into S. epidermidis was accomplished by electroporation or phage transduction with phage 187. Electroporation of S. epidermidis was performed using plasmids isolated from E. coli strain DC10B (Monk et al., 2012; Maliszewski and Nuxoll, 2014) . Transduction by phage 187 was performed according to Winstel et al., with S. aureus PS187DhsdRDSauUS1 carrying the respective plasmid as the donor strain (Winstel et al., 2015 (Winstel et al., , 2016 . S. epidermidis double and triple mutants were created by phage crosses with phage 71 (Dean et al., 1973; Olson and Horswill, 2014) or phage A6C (Rohde et al., 2005) .
Microtiter biofilm assay
Strains were picked from TSB agar plates and grown overnight in BHI, then diluted 1:200 in 50% BHI. 10 mg/ml chloramphenicol was added at both steps to cultures where necessary to maintain plasmids. 1 ml/well of the 1:200 subculture was added to a 48-well tissue culture-treated plate. Plates were incubated without shaking at 37 8C for 18-20 h, then media was aspirated and biomass was washed once by pipetting gently with 750 ml per well of sterile dH 2 O. Adherent biomass was stained with 1 ml per well 0.1% crystal violet for 5 minutes, then washed once with 1 ml sterile dH 2 O by gently pipetting. Final stained biomass was solubilized in 1 ml per well isopropanol and transferred to a 96-well plate with 200 ml per well to measure absorbance at 600 nm on a Tecan plate reader. For Aureolysintreated biofilms, purified S. aureus Aureolysin (BioCentrum) suspended in PBS was added to biofilms at time 0.
Flow cell biofilm assay
Flow cell apparatus was set up as previously described (Boles and Horswill, 2008) . Briefly, flow cell channels were created by gluing acid-etched coverslips to polycarbonate chambers. Overnight cultures grown in BHI were diluted 1:100 in BHI and injected into chambers, where bacteria were allowed to attach for 1 h at room temperature before flow was initiated. The biofilms were grown for 40-45 h in a 37 8C room, with media flow of 2% BHI at a pump speed of 3.25 RPM. After growth, the chambers were injected with BacLight live/dead stain (Thermo Fisher Scientific) according to the manufacturer's protocol and imaged by confocal microscopy. The 3D images from the confocal microscopy were generated with ImageJ Fiji software (Schindelin et al., 2012) and biomass was quantified using Comstat 2.1 (Heydorn et al., 2000; Vorregaard, 2008) .
Aap western blot of cell wall samples
To isolate cell walls, strains were grown statically in 5 ml of 50% BHI for 16.5 h to mimic biofilm assay conditions. Cells were harvested by centrifugation at 4000g for 5 minutes at 4 8C, then washed in 2 ml cold 50 mM Tris and 1 mM EDTA (TE) pH 8.0 with 13 protease inhibitor cocktail (Sigma). After a second centrifugation, cell pellets were resuspended to a total volume of 100 ml in TE pH 8.0 with 20% sucrose and 13 protease inhibitor cocktail. 10 mg lysostaphin was added to each sample, and samples were incubated at 37 8C for 15 minutes. Samples were centrifuged at 13,000g for 10 minutes and supernatants were collected and quantified by the BioRad Bradford assay using BSA as a standard. Samples were diluted to equal protein concentrations, loaded at 1 mg per well on a 4%-20% gradient SDS-PAGE gel, and blotted to 0.2 mM pore size PVDF using a Turbo transfer blot apparatus.
For the Aap Western blot, the membrane was incubated for one hour in blocking buffer of 5% milk in PBS, overnight in primary rabbit anti-Aap B domain antibody (Rohde et al., 2005 (Rohde et al., , 2007 diluted 1:100,000 in 5% milk in PBS 1 0.1% Tween 20, and for 1 h in secondary IR800-labeled goat-anti rabbit (Licor) diluted 1:20,000 in 5% milk in PBS 1 0.1% Tween 20. Between steps, the membrane was washed with PBS 1 0.1% Tween 20. Before imaging, the membrane was washed with PBS to remove Tween. Imaging was performed on a Licor Odyssey scanner.
Expression of recombinant Aap domains
Expression and purification of recombinant, His 6 -tagged Aap domain A (amino acids 54-614) was carried out essentially as described (Rohde et al., 2005) . For expression of a N-terminally His 6 -tagged protein spanning the predicted 212 amino acid lectin-like domain and the repetitive B domain (amino acids 398-1507), the corresponding coding region was amplified using primers aap1165_for and aap1785_rev and genomic DNA from S. epidermidis 5179 as a template. Purified amplicons were cloned into pENTR/ D-TOPO and subsequently subcloned into pDEST17, giving pDESTdomain B 1 212. Correctness of clones was validated using restriction digestion and sequencing of vector -insert junctions. rDomain-B_LLD and His 6 -tagged recombinant domain A were expressed and purified essentially as described (Rohde et al., 2005) .
Aap proteolysis assay and N-terminal sequencing
Supernatants were obtained from cultures of S. epidermidis 1457-M10, 1457-M10DsarA and corresponding mutants defective in expression of sepA, esp, or ecp. Supernatants from 50 ml overnight cultures were cleared by centrifugation, and subsequently 10-fold concentrated using centrifuge cartridges (molecular weight cut-off 10,000 Da; Merck Millipore, Darmstadt, Germany). Recombinant rDomain A (10 mg) or rDomain B 1 212 (10 mg) were incubated with 5 ml concentrated culture supernatants at 37 8C. Samples were heated at 708C in LDS buffer for 7 min, and then separated by SDS-PAGE using 4%-15% Bis-Tris gradient gels (Invitogen, Karlsruhe, Germany). Proteins were made visible using Coomassie staining. In some experiments, proteins were detected by Western blot using anti-His6 IgG (1:10,000) and peroxidase-coupled anti-mouse IgG (1:10,000). N-terminal sequencing by Edman degradation and mass spectrometry has been described elsewhere (Sturenburg et al., 2002) .
Quantification of sepA, ecp and esp expression
For the analysis of differential gene expression, triplicates of overnight cultures of strains 1457-M10 and 1457-M10DsarA were diluted 1:100 and grown for 6 and 18 h in 20 ml of tryptic soy broth (TSB) respectively. RNA was isolated as described previously (Franke et al., 2007) . Briefly, bacteria were immersed in RNAprotect Bacteria reagent (Qiagen, Hilden, Germany) and lysed. RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) and a sample volume containing 1 mg of RNA was digested twice by use of DNA-free DNase (Ambion, Life Technologies, Darmstadt, Germany). A volume of 5 ml of DNase-digested RNA was reverse-transcribed, using the iScript cDNA Synthesis Kit (BioRad, Hercules, CA, USA). The resulting cDNA was frozen immediately at 280 8C until further use.
Relative quantification of gene expression was performed on a Light Cycler 480 (Roche Applied Science, Mannheim, Germany). The staphylococcal housekeeping genes gyrB, rho and tpiA, coding for DNA gyrase subunit B, transcription termination factor rho and triosephosphate isomerase tpiA, respectively, were used as internal reference genes (Theis et al., 2007; Crawford et al., 2014; Sihto et al., 2014) . The TaqMan Fast Advanced Master Mix 23 (Thermo Fisher Scientific) was used according to the manufacturer's instructions, duplicates of the reaction were set up manually in a reaction volume of 15 ml.
All primers and probes were designed using Primer3 (Koressaar and Remm, 2007; Untergasser et al., 2012) and are listed in Supporting Information Table S2 . The hydrolysis probes contain FAM as fluorophore and BHQ1 as quencher. All primers and probes were synthesized by MWG Eurofins, Germany. Cycling and subsequent analysis of qPCR data was performed as described previously (Weiser et al., 2016) . Values were assumed to be normally distributed and the two-tailed Student's t-test was performed with the significance level set to 0.017 to account for multiple testing.
SepA activity assay
Overnight cultures grown in TSB were diluted to an OD 600 of 0.2 in TSB and allowed to grow for 3 h. Cultures were filtered through Spin-X tubes and the filtrates were tested for SepA activity as previously described (Kavanaugh et al., 2007) . 20 ml reactions were set up containing 15 ml of spent media with fluorescein-labelled substrate at a final concentration of 150 mM. Reactions were buffered to 20 mM TrisHCl pH 8.0. EDTA was added at 1 mM for SepA inhibition reactions. Reactions were incubated at 37 8C for 3 h, then 20 ml of 50% glycerol was added to each reaction to enable loading in an agarose gel. 20 ml of each reaction was loaded on an agarose gel and imaged using a GelDoc camera.
Ecp activity assay
Overnight cultures were diluted to an OD 600 of 0.1 and grown in 25 ml TSB in 125 ml flasks. At each time point, 500 ml was removed from each culture and filtered through Spin-X tubes. The resulting spent media were tested for Ecp activity using the FRET substrate based on CXCR2, with the sequence (5-FAM)-Lys-Leu-Leu-Asp-Ala-Ala-ProLys-(QXL520)-OH (AnaSpec, Fremont, CA) . Spent media from each culture was buffered by mixing 2 ml of 2 M Tris-HCl pH 7.4 with 198 ml spent media. In a black 96 well microtiter plate, 10 ml of 50 mM FRET substrate in dH 2 O was mixed with 90 ml buffered spent media and incubated in a TECAN plate reader at 37 8C for 30 minutes, with fluorescence (Excitation 490, Emission 520) measured every minute with the gain set to 100. Activity is calculated as the slope of the fluorescence over time.
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